Sinovac gets WHO nod for emergency use of Covid-19 vaccine CoronaVac
The vaccine has been recommended for use in people aged 18 years and above
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Jun 21
The vaccine has been recommended for use in people aged 18 years and above
02 Jun 21
BridgeBio, through its affiliate QED and partner Helsinn, intends to co-commercialise the cholangiocarcinoma drug in the US
31 May 21
MHRA approved Covid-19 Vaccine Janssen after meeting the required safety, quality and effectiveness standards
31 May 21
The EC approval is based on results from the Phase 3 ADAURA trial, in which Tagrisso reduced the…
28 May 21
Zeposia is claimed to be the first and only S1P receptor modulator approved for treating moderately to severely…
27 May 21
In Phase 3 COMET-ICE trial, sotrovimab reduced 85% risk of hospitalisation or death in high-risk adult patients compared…
26 May 21
Venclyxto-based combination treatments are indicated for adults with newly diagnosed AML, who are not eligible for intensive chemotherapy
24 May 21
The US FDA has also approved Guardant Health's Guardant360 CDx liquid biopsy blood test as a companion diagnostic…
21 May 21
The FDA approval expands the role of Opdivo in earlier stages of the disease, with two indications across…
17 May 21
The US FDA approval of Empaveli is based on results from the head-to-head Phase 3 PEGASUS study